An international team of scientists with over 30 years combined experience in genomics and healthcare

An international team of scientists
with over 30 years combined experience
in genomics and healthcare

The Allelica team is dedicated to advancing common disease risk prediction across health systems in the US and around the world.

The Allelica team is dedicated to advancing common disease risk prediction
across health systems in the US and around the world.

Advisory Board

Aleksandar Rajkovic | MD PhD
Chief Genomics Officer, UCSF Health Center for Clinical Genetics and Genomics

Biography

Dr. Rajkovic is the UCSF Chief Genomics Officer, Professor of Pathology, and the Medical Director and Chief of the Center for Genetic and Genomic Medicine in the UCSF Health System.

Prior to his position at UCSF, he was the Chief of Medical and Laboratory Genetics at the University of Pittsburgh Medical Center where he oversaw Pittsburgh molecular genomic laboratories as well as adult/cancer clinical services.

Dr. Rajkovic is also the Director of the Genomic Medicine Initiative, a translational arm of the Institute of Human Genetics.

He has served as a member and director on numerous NIH study sections and workshops, March of Dimes advisory committee on prematurity and American College of Obstetrics and Gynecology Committee on Genetics.

His research investigates the use of genetics data for large scale implementation and the genetic underpinnings of the formation and differentiation of gametes and reproductive tract, their role of these genes in human disease, embryo lethality and origin of heritable human disorders.

Scroll to read more

Gordon S. Huggins | MD
Director, Molecular Cardiology Research Institute,
Tufts University School of Medicine

Biography

Dr. Huggins is the Director of the Molecular Cardiology Research Institute (MCRI) Center for Translational Pharmacology and Genomics, Associate Professor at Tufts University School of Medicine, and a practicing cardiologist. He led the NHLBI Heart Failure Network program at Tufts and co-directed the Committee on Participation of Women in Heart Failure Clinical Trials.

Previously, Dr. Huggins spent four years at The Massachusetts General Hospital in the Cardiology Division where he completed his clinical training.

In addition to his work in Tufts Medical Center, he is also a faculty member at Tufts Graduate School of Biomedical Sciences Clinical Translational Sciences Program, Genetics Program and Cell, Molecular and Developmental Biology Program.

His research interest is focused on making scientific discoveries relevant to human diseases that may translate to new biomarkers or therapies.

Scroll to read more

Noura S. Abul-Husn | MD PhD
Clinical Director, Institute for Genomic Health,
Icahn School of Medicine at Mount Sinai

Biography

Dr. Abul-Husn is the founding Chief of the Division of Genomic Medicine in the Department of Medicine, and Clinical Director of the Institute for Genomic Health at the Icahn School of Medicine at Mount Sinai. She is an Associate Professor of Medicine and Genetics and board certified in Internal Medicine and Medical Genetics.

Dr. Abul-Husn is an expert at leveraging large-scale genomic data linked to electronic health records. Her work has been published in leading journals, including Science, Cell, and the New England Journal of Medicine.

She is also a principal investigator in the eMERGE (electronic Medical Records and Genomics) Network.

Dr. Abul-Husn has senior-level pharmaceutical industry experience, having served as director of Translational Genetics at the Regeneron Genetics Center.

Her research is focused on uncovering the clinical impact of human genetic variation in diverse populations and driving the equitable implementation of genomic medicine.

Scroll to read more

Bjarni Jóhann Vilhjálmsson | PhD
Professor at Department of Economics and Business Economics, Aarhus University

Biography

Dr. Vilhjálmsson is a Professor at the National Centre for Register-based Research and at the Bioinformatics Research Centre at Aarhus University. Vilhjalmsson is a statistical geneticist who is motivated to leverage large population-scale data to understand the interplay between genetic and environmental factors when determining the causes of disease. He currently leads a research group at Aarhus University that is focused on developing methods that integrate electronic health records and large genetic data to understand psychiatric disorders and other diseases.

He is the author of LDpred, one of the most cited methods and software for deriving Polygenic risk Scores (PRS). LDpred contributed significantly to the development of the entire PRS field, having been used in a number of PRS seminal papers that have highlighted the value of PRSs in clinical settings.

Dr. Vilhjálmsson completed his PhD in Computational Biology from the University of Southern California in 2011, and went on to do postdoctoral research at Harvard School of Public Health, Harvard University, and later at the Bioinformatics Research Centre (BiRC) of Aarhus University. In 2016 Dr. Vilhjalmsson left academia to work as a software product owner at QIAGEN, but rejoined academia at Aarhus University to establish his own research group. Dr. Vilhjalmsson was awarded the prestigious Lundbeck Fellow grant in 2020.

Scroll to read more

Alessandro Boccanelli | MD
Director of the Italian Society of Geriatric Cardiology, Professor, Uni Camillus

Biography

Professor Alessandro Boccanelli is the current President of the Italian Society of Geriatric Cardiology (SICGE) and in 2002-2004 served as the President of ANMCO, the National Association of Hospital Cardiologists.

He has worked at the Cardiological Hospital of Ancona, Saint Camillus Hospital, and Saint John’s Hospital in Rome where he was the Director of the Department for Cardiovascular Diseases (1998-2013).

He is a Professor of Medicine at Uni Camillus, International University of Health and Medical Sciences, and a practicing cardiologist at Quisisana, a world class cardiac care and cardiological rehabilitation center.

In 2013, he founded the non profit association “Salute e Società” which is focused on improving the relationship between healthcare, welfare and society.

He is the author of over 300 scientific publications in national and international medical journals.

Scroll to read more

Gualtiero Colombo | MD PhD
Director, Functional Genomics Lab,
Monzino Hospital

Biography

Dr. Colombo is the Head of the Unit of Immunology and Functional Genomics and Head of the Open Innovation Area at the Monzino IRCCS Cardiology Center, Milan.

He specializes in Allergology and Clinical Immunology and has a PhD in Biotechnology in the Medical Sciences.

He previously taught at the Schools of Specialization in Hygiene and Preventive Medicine, Infectious Diseases and Tropical Medicine and the School of Medicine at the University of Milan. Dr. Colombo has also carried out clinical and research activities at the Department of Internal Medicine of the University of Milan and the Policlinico Hospital in Milan.

His main areas of research focus on the genetics and genomics of atherosclerosis and cardiovascular disease, and the identification of new molecular biomarkers of cardiovascular diseases.

Dr. Colombo has been published in over 65 international scientific journals including Circulation Research, Arteriosclerosis Thrombosis and Vascular Biology, Bioinformatics, and the European Heart Journal.

Scroll to read more

Giordano Bottà | PhD

CEO & Co-Founder


Giordano is a biologist with a PhD in Public Health. During his career as a researcher he had the opportunity to work with some of the top genomics experts in the world at the University of Oxford publishing in the journal Nature. He wants to give people the opportunity to benefit from the scientific revolution happening in genomics by creating digital products that allow the extraordinary information carried in our DNA to be used effectively.


Giordano is a biologist with a PhD in Public Health.
During his career as a researcher he had the
opportunity to work with some of the top genomics
experts in the world at the University of Oxford publishing
in the journal Nature. He wants to give
people  the opportunity to benefit from the scientific
revolution happening in genomics by creating digital 
products that  allow the extraordinary information
carried in our DNA to  be used effectively.

Field: Molecular Biology & Bioinformatics

Paolo Di Domenico

CTO & Co-Founder

Paolo is a software engineer. He programmed his first
software in Basic at the age of 5 with a Commodore 64.
Since then he has gained experience in numerous
programming languages and in designing complex cloud
architecture. His goal is to develop algorithms and
software that can translate the latest scientific findings in
genomic prediction into clinical practice.

Paolo is a software engineer. He programmed his first software in Basic at the age of 5 with a Commodore 64.Since then he has gained experience in numerous programming languages and in designing complex cloud architecture. His goal is to develop algorithms and software that can translate the latest scientific findings in genomic prediction into clinical practice.

Field: Software Engineering & Data Mining

George Busby | PhD

CSO & Co-Founder

George is a statistical geneticist and science communicator. He has worked at the University of Oxford for more than 10 years and his scientific work has been published in Nature and Science, amongst other journals. He has always been fascinated by the potential of DNA to be used to reconstruct human evolutionary history by analyzing large genomic datasets with advanced statistical modeling.
He now leads Allelica's scientific team, helping to bring polygenic risk scores to the market for the first time by showing their use in medical genetics.

George is a statistical geneticist and science
communicator. He has worked at the University of
Oxford for more than 10 years and his scientific work
has been published in Nature and Science, amongst
other journals. He has always been fascinated by the
potential of DNA to be used to reconstruct human
evolutionary history by analyzing large genomic
datasets with advanced statistical modeling. He now
leads Allelica's scientific team, helping to bring polygenic
risk scores to the market for the first time by showing
their use in medical genetics.

Field: Genomics & Writing

Buu Truong

Visiting Scientist


Field: Statistical Genetics

Colleen Lyons

Business Development


Field: Marketing & Science

Deo Mujwara

Health Economist


Field: Healthcare Policy & Research

Alessandro Bolli | PhD

Head of Data Science


Field: Data Analysis

Paul Craig

Bioinformatician


Field: Predictive Modelling & Statistics

Samir Gahramanov

Software Engineer


Field: Software & Cloud-architecture

Saurabh Hebbalkar

Software Engineer


Field: Software & Artificial Intelligence

Andrea Amedeo

Project Assistant


Field: Communication & Technology